Amedeo Smart

Free Medical Literature Service


 

Amedeo

Cytomegalovirus Infection

  Free Subscription

Articles published in
J Heart Lung Transplant
    June 2021
  1. ORESCHAK K, Saba LM, Rafaels N, Ambardekar AV, et al
    Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.
    J Heart Lung Transplant. 2021 Jun 12. pii: S1053-2498(21)02342.
    >> Share

    May 2021
  2. VIETZEN H, Hartenberger S, Jaksch P, Puchhammer-Stockl E, et al
    Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients.
    J Heart Lung Transplant. 2021 May 31. pii: S1053-2498(21)02324.
    >> Share

    November 2020
  3. KANWAR MK, Khush KK, Pinney S, Sherman C, et al
    Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients.
    J Heart Lung Transplant. 2020 Nov 22. pii: S1053-2498(20)31840.
    >> Share

    August 2020
  4. STANKOVIC S, Davey MS, Shaw EM, von Borstel A, et al
    Cytomegalovirus replication is associated with enrichment of distinct gammadelta T cell subsets following lung transplantation: A novel therapeutic approach?
    J Heart Lung Transplant. 2020 Aug 26. pii: S1053-2498(20)31703.
    >> Share

    April 2020
  5. VP RIBEIRO R, Ku T, Ferreira VH, Galasso M, et al
    Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion.
    J Heart Lung Transplant. 2020;39.
    >> Share

  6. KANWAR M, Pinney S, Shah P, Kobashigawa J, et al
    Correlation of Longitudinal Gene-Expression Profiling (GEP) Score to Cytomegalovirus (CMV) Infection: Results from the Outcomes Allomap(R) Registry.
    J Heart Lung Transplant. 2020;39.
    >> Share

  7. STANKOVIC S, Davey MS, Shaw EM, Cristiano Y, et al
    A Potential Role for NKG2C+ gammadelta T Cells as a Cellular Therapy in Combating Post-Lung Transplant Cytomegalovirus Infection.
    J Heart Lung Transplant. 2020;39.
    >> Share

  8. PIERCE BJ, Pham C, Balk SV, Huang H, et al
    Cytomegalovirus Immune Globulin (CMV-Ig): An Old Drug with Fewer Tricks - Removal of Prophylactic CMV-Ig Administration in CMV Mismatched Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    >> Share

  9. GIFT T, Palafox J, Jones K, Imburgia T, et al
    CMV Viremia after Discontinuation of Valganciclovir Prophylaxis in Lung Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    >> Share

  10. MOSS I, Brueckner A, Rumore A
    Comparison of Outcomes in Heart Transplant Recipients Receiving CMV Prophylaxis with CMV IVIG with Valganciclovir versus Valganciclovir Alone.
    J Heart Lung Transplant. 2020;39.
    >> Share

  11. COUTANCE G, Boutolleau D, Rouvier P, Leprince P, et al
    Cytomegalovirus Infections are Frequent after Heart Transplantation but Do Not Increase the Risk of Biopsy-Proven Allograft Rejection in the Modern Era.
    J Heart Lung Transplant. 2020;39.
    >> Share

  12. PUING A, Couture-Cosette A, Quintero O, Multani A, et al
    6-month vs 12-month CMV Prophylaxis for CMV-Mismatched Heart Transplant Recipients.
    J Heart Lung Transplant. 2020;39.
    >> Share

  13. CALLAN PD, Yonan N, Santhanakrishnan K, Shaw SM, et al
    Does CMV Status Impact on Morbidity and Survival Following Heart Transplantation? A Large Multi-Centre Retrospective UK Study.
    J Heart Lung Transplant. 2020;39.
    >> Share

    January 2020
  14. POGLAJEN G, Zemljic G, Frljak S, Cerar A, et al
    QuantiFERON-CMV guided virostatic prophylaxis after heart transplantation.
    J Heart Lung Transplant. 2020 Jan 21. pii: S1053-2498(20)30010.
    >> Share

    September 2019
  15. HELIOVAARA E, Husain S, Martinu T, Singer LG, et al
    Drug-resistant cytomegalovirus infection after lung transplantation: Incidence, characteristics, and clinical outcomes.
    J Heart Lung Transplant. 2019 Sep 10. pii: S1053-2498(19)31672.
    >> Share

    January 2019
  16. MOAYEDI Y, Gomez CA, Fan CPS, Miller RJH, et al
    Infectious complications after heart transplantation in patients screened with gene expression profiling.
    J Heart Lung Transplant. 2019 Jan 7. pii: S1053-2498(19)30006.
    >> Share

    July 2017
  17. VIETZEN H, Gorzer I, Honsig C, Jaksch P, et al
    Association between antibody functions and human cytomegalovirus (HCMV) replication after lung transplantation in HCMV-seropositive patients.
    J Heart Lung Transplant. 2017 Jul 18. pii: S1053-2498(17)31901.
    >> Share

    May 2017
  18. SARMIENTO E, Jaramillo M, Calahorra L, Fernandez-Yanez J, et al
    Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
    J Heart Lung Transplant. 2017;36:529-539.
    >> Share

    August 2016
  19. FORCONI C, Gatault P, Miquelestorena-Standley E, Noble J, et al
    Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    J Heart Lung Transplant. 2016 Aug 26. pii: S1053-2498(16)30295.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016